Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Cancer progression by non-clonal chromosome aberrations.

Heng HH, Bremer SW, Stevens J, Ye KJ, Miller F, Liu G, Ye CJ.

J Cell Biochem. 2006 Aug 15;98(6):1424-35. Review.

PMID:
16676347
2.

Stochastic cancer progression driven by non-clonal chromosome aberrations.

Heng HH, Stevens JB, Liu G, Bremer SW, Ye KJ, Reddy PV, Wu GS, Wang YA, Tainsky MA, Ye CJ.

J Cell Physiol. 2006 Aug;208(2):461-72.

PMID:
16688757
3.

Clonal and non-clonal chromosome aberrations and genome variation and aberration.

Heng HH, Liu G, Bremer S, Ye KJ, Stevens J, Ye CJ.

Genome. 2006 Mar;49(3):195-204. Review.

PMID:
16604101
4.

The dynamics of cancer chromosomes and genomes.

Ye CJ, Liu G, Bremer SW, Heng HH.

Cytogenet Genome Res. 2007;118(2-4):237-46. Review.

PMID:
18000376
5.

Why it is crucial to analyze non clonal chromosome aberrations or NCCAs?

Heng HH, Regan SM, Liu G, Ye CJ.

Mol Cytogenet. 2016 Feb 13;9:15. doi: 10.1186/s13039-016-0223-2. eCollection 2016.

6.

Cancer genome sequencing: the challenges ahead.

Heng HH.

Bioessays. 2007 Aug;29(8):783-94. Review. Erratum in: Bioessays. 2007 Oct;29(10):1070.

PMID:
17621658
7.

Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.

Heng HH, Bremer SW, Stevens JB, Ye KJ, Liu G, Ye CJ.

J Cell Physiol. 2009 Sep;220(3):538-47. doi: 10.1002/jcp.21799. Review.

PMID:
19441078
8.

Genome based cell population heterogeneity promotes tumorigenicity: the evolutionary mechanism of cancer.

Ye CJ, Stevens JB, Liu G, Bremer SW, Jaiswal AS, Ye KJ, Lin MF, Lawrenson L, Lancaster WD, Kurkinen M, Liao JD, Gairola CG, Shekhar MP, Narayan S, Miller FR, Heng HH.

J Cell Physiol. 2009 May;219(2):288-300. doi: 10.1002/jcp.21663.

9.

The evolutionary mechanism of cancer.

Heng HH, Stevens JB, Bremer SW, Ye KJ, Liu G, Ye CJ.

J Cell Biochem. 2010 Apr 15;109(6):1072-84. doi: 10.1002/jcb.22497. Review.

PMID:
20213744
10.

Chromosome aberrations in solid tumors.

Albertson DG, Collins C, McCormick F, Gray JW.

Nat Genet. 2003 Aug;34(4):369-76. Review.

PMID:
12923544
11.

Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer.

Zieger K, Wiuf C, Jensen KM, Ørntoft TF, Dyrskjøt L.

BMC Cancer. 2009 May 16;9:149. doi: 10.1186/1471-2407-9-149.

12.

Primary vs. secondary neoplasia-associated chromosomal abnormalities--balanced rearrangements vs. genomic imbalances?

Johansson B, Mertens F, Mitelman F.

Genes Chromosomes Cancer. 1996 Jul;16(3):155-63.

PMID:
8814447
13.

Cytogenetic heterogeneity: its role in tumor evolution.

Wolman SR.

Cancer Genet Cytogenet. 1986 Jan 1;19(1-2):129-40.

PMID:
3455660
14.

Cancer chromosomes in crisis.

DePinho RA, Polyak K.

Nat Genet. 2004 Sep;36(9):932-4.

PMID:
15340427
15.

Genomic mechanisms and measurement of structural and numerical instability in cancer cells.

Bayani J, Selvarajah S, Maire G, Vukovic B, Al-Romaih K, Zielenska M, Squire JA.

Semin Cancer Biol. 2007 Feb;17(1):5-18. Epub 2006 Oct 26. Review.

PMID:
17126026
16.

Power law distribution of chromosome aberrations in cancer.

Frigyesi A, Gisselsson D, Mitelman F, Höglund M.

Cancer Res. 2003 Nov 1;63(21):7094-7.

17.

The evolutionary origin of genetic instability in cancer development.

Breivik J.

Semin Cancer Biol. 2005 Feb;15(1):51-60. Review.

PMID:
15613288
18.

Coping with complexity. multivariate analysis of tumor karyotypes.

Höglund M, Gisselsson D, Säll T, Mitelman F.

Cancer Genet Cytogenet. 2002 Jun;135(2):103-9. Review.

PMID:
12127394
19.

Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype?

Natrajan R, Lambros MB, Geyer FC, Marchio C, Tan DS, Vatcheva R, Shiu KK, Hungermann D, Rodriguez-Pinilla SM, Palacios J, Ashworth A, Buerger H, Reis-Filho JS.

Genes Chromosomes Cancer. 2009 Apr;48(4):351-65. doi: 10.1002/gcc.20646.

PMID:
19156836
20.

Primary chromosome abnormalities in human neoplasia.

Heim S, Mitelman F.

Adv Cancer Res. 1989;52:1-43. Review.

PMID:
2662710
Items per page

Supplemental Content

Write to the Help Desk